1-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-3-[5-(5-thiophen-2-yl-1H-imidazol-2-yl)-pyridin-2-yloxy]-propan-2-ol

ID: ALA11178

PubChem CID: 13621796

Max Phase: Preclinical

Molecular Formula: C25H28N4O4S

Molecular Weight: 480.59

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(CCNCC(O)COc2ccc(-c3nc(-c4cccs4)c[nH]3)cn2)cc1OC

Standard InChI:  InChI=1S/C25H28N4O4S/c1-31-21-7-5-17(12-22(21)32-2)9-10-26-14-19(30)16-33-24-8-6-18(13-27-24)25-28-15-20(29-25)23-4-3-11-34-23/h3-8,11-13,15,19,26,30H,9-10,14,16H2,1-2H3,(H,28,29)

Standard InChI Key:  CHGOMLLLZPHCNH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   -1.5250   -1.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5083   -2.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6875   -2.2917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2458   -1.0792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8500   -1.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7750   -1.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9125   -3.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6542   -1.1500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4958   -3.8167    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.7750   -0.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6542   -0.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0625   -1.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7208   -3.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6042   -1.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0375   -4.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1500   -0.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7708   -0.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7958   -4.1125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3667    0.0958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8292   -1.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0583    0.0958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3667   -0.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8000    0.0958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0792   -0.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2125   -1.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5542   -0.3417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2292    0.0958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2292   -1.9542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8000    0.9208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5125   -0.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9417   -0.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6542    0.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1750   -0.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0667   -2.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  1  2  0
  4  1  1  0
  5  4  1  0
  6  1  1  0
  7  2  1  0
  8 12  2  0
  9  7  1  0
 10 16  1  0
 11 21  2  0
 12  6  1  0
 13  7  2  0
 14 20  1  0
 15  9  1  0
 16 22  2  0
 17  6  2  0
 18 13  1  0
 19 11  1  0
 20 25  2  0
 21 17  1  0
 22 32  1  0
 23 24  1  0
 24 19  1  0
 25 22  1  0
 26 10  1  0
 27 30  1  0
 28 14  1  0
 29 23  1  0
 30 23  1  0
 31 27  1  0
 32 31  1  0
 33 26  1  0
 34 28  1  0
  5  2  2  0
  8 11  1  0
 18 15  2  0
 14 10  2  0
M  END

Associated Targets(Human)

ADRB1 Tclin Adrenergic receptor beta; ADRB1 & ADRB2 (240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ADRB1 Beta-1 adrenergic receptor (895 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adrb2 Beta-2 adrenergic receptor (1382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 480.59Molecular Weight (Monoisotopic): 480.1831AlogP: 3.79#Rotatable Bonds: 12
Polar Surface Area: 101.52Molecular Species: BASEHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.91CX Basic pKa: 9.31CX LogP: 3.61CX LogD: 1.71
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.27Np Likeness Score: -1.12

References

1. Baldwin JJ, Christy ME, Denny GH, Habecker CN, Freedman MB, Lyle PA, Ponticello GS, Varga SL, Gross DM, Sweet CS..  (1986)  Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2.,  29  (6): [PMID:2872332] [10.1021/jm00156a028]

Source